| Net Cash Provided by (Used in) Operating Activities |
$542,221,000 |
USD |
586% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$201,794,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
1,000,000,000 |
shares |
0% |
Q4 2025 |
FY 2025 |
| Common Stock, Shares, Issued |
464,047,623 |
shares |
119% |
Q4 2025 |
FY 2025 |
| Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q4 2025 |
FY 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$744,015,000 |
USD |
2314% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$282,924,000 |
USD |
10% |
Q4 2025 |
FY 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$32,780,000 |
USD |
-19% |
Q1 2025 |
Q1 2025 |
| Additional Paid in Capital |
$7,573,712,000 |
USD |
126% |
Q4 2025 |
FY 2025 |
| Interest Expense |
$321,492,000 |
USD |
67% |
Q4 2025 |
FY 2025 |